Assessment of vascular involvement
- PMID: 12889215
Assessment of vascular involvement
Abstract
Our objective was to identify a core set of variables for the assessment of vascular involvement in scleroderma that is simple, reproducible, and reflects the presence of vascular disease in SSc. To do so we carried out an extensive literature review of published studies relating to the assessment of vascular involvement in SSc, i.e. studies dealing with clinical parameters, functional vascular studies, cold presser testing, nailfold capillary microscopy and circulating vascular markers. After extensive review of published studies and critical assessment of proposed vascular parameters, the subcommittee endorsed what it considers to be the minimal requirements for the documentation of vascular involvement in SSc. The core set variables include two parameters: Raynaud's phenomenon and digital ulcers. This set is simple, reproducible and should be included in the assessment of SSc patients in clinical investigational studies. The subcommittee also however recognizes that there exists a promising set of vascular variable that still needs further investigation.
Similar articles
-
Assessment of lung involvement.Clin Exp Rheumatol. 2003;21(3 Suppl 29):S19-23. Clin Exp Rheumatol. 2003. PMID: 12889217 Review.
-
Assessment of gastrointestinal involvement.Clin Exp Rheumatol. 2003;21(3 Suppl 29):S15-8. Clin Exp Rheumatol. 2003. PMID: 12889216 Review.
-
Vascular complications of scleroderma.Autoimmun Rev. 2007 Sep;6(8):520-3. doi: 10.1016/j.autrev.2006.12.006. Epub 2007 Jan 12. Autoimmun Rev. 2007. PMID: 17854742 Review.
-
Assessment of kidney involvement.Clin Exp Rheumatol. 2003;21(3 Suppl 29):S29-31. Clin Exp Rheumatol. 2003. PMID: 12889219 Review.
-
Assessment of disease activity.Clin Exp Rheumatol. 2003;21(3 Suppl 29):S39-41. Clin Exp Rheumatol. 2003. PMID: 12889221 Review.
Cited by
-
Capillary dimension measured by computer-based digitalized image correlated with plasma endothelin-1 levels in patients with systemic sclerosis.Clin Rheumatol. 2010 Mar;29(3):247-54. doi: 10.1007/s10067-009-1288-7. Epub 2009 Dec 31. Clin Rheumatol. 2010. PMID: 20043182 Clinical Trial.
-
Pathogenesis of Systemic Sclerosis.Front Immunol. 2015 Jun 8;6:272. doi: 10.3389/fimmu.2015.00272. eCollection 2015. Front Immunol. 2015. PMID: 26106387 Free PMC article. Review.
-
Results of a Pilot Randomized Placebo-Controlled Trial in Primary and Secondary Raynaud's Phenomenon with St. John's Wort: Detecting Changes in Angiogenic Cytokines When RP Improves.ISRN Rheumatol. 2011;2011:580704. doi: 10.5402/2011/580704. Epub 2011 Sep 12. ISRN Rheumatol. 2011. PMID: 22389797 Free PMC article.
-
Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control.Ann Rheum Dis. 2007 Oct;66(10):1305-10. doi: 10.1136/ard.2006.064493. Epub 2007 Mar 14. Ann Rheum Dis. 2007. PMID: 17360781 Free PMC article.
-
New lines in therapy of Raynaud's phenomenon.Rheumatol Int. 2009 Feb;29(4):355-63. doi: 10.1007/s00296-008-0792-4. Epub 2008 Nov 27. Rheumatol Int. 2009. PMID: 19037602 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical